Resource Centre

FINAL RWE38 ICE-PT

A retrospective cohort study of the clinical outcomes of ILUVIEN in four ophthalmology centres in Portugal (ICEPT)

SVMPharma’s real-world evidence helped deliver a unique real-world multicentre study in Portugal (ICEPT) looking at the clinical outcomes of fluocinolone acetonide implant (ILUVIEN®) in clinical practice for diabetic macular oedema (DMO) patients. Our real-world evidence provided valuable insights and helped show a marked reduction in odema in 66% of DMO patients’ eyes (n=75) in real-world clinical practice.   A retrospective cohort study […]

Read More
FINAL RWE36 ICE infographic

SVMPharma’s real-world studies in diabetic eye oedema led to multiple successful publications and congress presentations in the UK and Europe

SVMPharma has recently collected real-world data in the UK and Europe for which has lead to successful outcomes from publications to presentations in a major European congress Click on the references below to find out more References (1) Currie CJ. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular […]

Read More
FINAL RWE37 CF infographic

First real-world multicentre study of the use of inhaled aztreonam lysine in clinical practice

SVMPharma’s Real World Treatment Evaluator tool helped deliver the first real-world multicentre study of the use of inhaled aztreonam lysine in clinical practice for cystic fibrosis (CF) patients. Our treatment evaluator tool provided valuable insights and demonstrated significant improvement in lung function in CF patients in a real-world setting.   A treatment evaluator tool to monitor the […]

Read More
FINAL_RWE infographic 30

Answering real world clinical questions with Real World Data

Click here or the image below to find out more Keywords: Real World Evidence, Real World Data, Retrospective, Prospective, Rapid outcomes, Clinical outcomes, Clinical Insights, Health Technology Assessment, The National Institute for Health and Care Excellence, NICE, Data Gaps, Post-Approval  

Read More
FINAL_RWE infographic 29

97% of Companies to Increase Use of Real World Patient Data

Click here or the image below to find out more Keywords: Real World Evidence, Real World Data, Retrospective, Prospective, Rapid outcomes, Clinical outcomes, Clinical Insights, Health Technology Assessment, The National Institute for Health and Care Excellence, NICE, Data Gaps, Post-Approval  

Read More
FINAL_RWE infographic 27

Who are the Real World Evidence Stakeholders?

Click here or the image below to find out more Keywords: Real World Evidence, Real World Data, Retrospective, Prospective, Rapid outcomes, Clinical outcomes, Clinical Insights, Health Technology Assessment, The National Institute for Health and Care Excellence, NICE, Data Gaps, Post-Approval  

Read More
004_FINAL_RWE infographic 26

NICE leads access to medical devices

Click here or the image below to find out more   Keywords:  Medical Device, FDA, Real World Evidence, Real World Data, Retrospective, Prospective, Rapid outcomes, Clinical outcomes, Clinical Insights, Health technology assessment, The National Institute for Health and Care Excellence, NICE, Data Gaps, Post-Approval

Read More
005_FINAL_A27

Turning Real World Data into Real World Evidence: identifying and overcoming RCT data gaps

Click here or the image below to find out more   Keywords:  SACT, Systemic Anti-Cancer Therapy, Oncology, Electronic Prescribing Records, Real World Evidence, Real World Data, Retrospective, Prospective, Overall Survival, Progression Free Survival, Response rates, Rapid outcomes, Treatment pathways, Clinical outcomes, Line of therapy and cycles, Clinical Insights, Health technology assessment, The National Institute for Health and Care Excellence, NICE, RCT, Registration Studies, Data […]

Read More
FINAL_RWE infographic 25

RWD and RWE: Where is the Value?

Click here or the image below to find out more Keywords:  SACT, Systemic Anti-Cancer Therapy, Oncology, Electronic Prescribing Records, Real World Evidence, Real World Data, Retrospective, Prospective, Overall Survival, Progression Free Survival, Response rates, Rapid outcomes, Treatment pathways, Clinical outcomes, Line of therapy and cycles, Clinical Insights, Health technology assessment, The National Institute for Health and Care Excellence, NICE, Resource implications, Payer communication

Read More
FINAL_RWE infographic 24

30% oncology NICE submissions not recommended

Click here or the image below to find out more Keywords:  SACT, Systemic Anti-Cancer Therapy, Oncology, Electronic Prescribing Records, Real World Evidence, Real World Data, Retrospective, Prospective, Overall Survival, Progression Free Survival, Response rates, Rapid outcomes, Treatment pathways, Clinical outcomes, Line of therapy and cycles, Clinical Insights, Health technology assessment, The National Institute for Health and Care Excellence, NICE

Read More
FINAL_SVMPharma oncology electronic prescribing_reviewed 18-09-2017

SACT vs. Oncology Electronic Prescribing Records

Click here or the image below to find out more Keywords:  SACT, Systemic Anti-Cancer Therapy, Oncology, Electronic Prescribing Records, Real World Evidence, Real World Data, Retrospective, Prospective, Overall Survival, Progression Free Survival, Response rates, Rapid outcomes, Treatment pathways, Clinical outcomes, Line of therapy and cycles, Clinical Insights

Read More
003_RWE 2 Infographic Layout-1

eyeforpharma EU Summit 2016: RWE survey results

75% of industry professionals polled at the efp EU Summit 2016 said internal and external barriers were among the top reasons stopping them from doing RWE projects. Find out more in our survey results below For more on the eyeforpharma EU Summit and RWE, see our presentation by clicking here    

Read More